RBC Capital Reiterates Rating on Hinge Health, Inc. $HNGE
Key Points
- RBC Capital now rates Hinge Health, Inc. ($HNGE) "buy" with a $75.00 target.
- The Street's average $HNGE price target is $76.80 (Buy).
- $HNGE last traded around $65.27.
RBC Capital reiterated its rating on Hinge Health, Inc. ($HNGE) to a "buy" rating, with a price target of $75.00 in a recent research note.
Hinge Health, Inc. ($HNGE) Stock
Hinge Health, Inc. Earnings
Analysts Set New Price Targets
About Hinge Health, Inc.
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.